Synonyms:Bafetinib, 859212-16-1, INNO-406, NS-187, UNII-NVW4Z03I9B, INNO406, INNO 406, (S)-N-(3-([4,5'-bipyrimidin]-2-ylamino)-4-methylphenyl)-4-((3-(dimethylamino)pyrrolidin-1-yl)methyl)-3-(trifluoromethyl)benzamide, CNS-9, NVW4Z03I9B, CHEMBL206834, 4-[[(3S)-3-DIMETHYLAMINOPYRROLIDIN-1-YL]METHYL]-N-[4-METHYL-3-[(4-PYRIMIDIN-5-YLPYRIMIDIN-2-YL)AMINO]PHENYL]-3-(TRIFLUOROMETHYL)BENZAMIDE, (S)-N-(3-(4,5'-bipyrimidin-2-ylamino)-4-methylphenyl)-4-((3-(dimethylamino)pyrrolidin-1-yl)methyl)-3-(trifluoromethyl)benzamide, N-[3-(4,5'-Bipyrimidin-2-Ylamino)-4-Methylphenyl]-4-{[(3s)-3-(Dimethylamino)pyrrolidin-1-Yl]methyl}-3-(Trifluoromethyl)benzamide, Bafetinib [USAN:INN], Bafetinib (USAN), NS 187, Bafetinib - INNO-406, GTPL7906, QCR-84, SCHEMBL2684766, SYN1179, DTXSID001006512, BCP22045, EX-A1534, BDBM50178612, NSC788186, NSC799354, s1369, ZINC22940637, CCG-270114, CS-5142, DB11851, NSC-788186, NSC-799354, NCGC00386698-02, NCGC00386698-03, AS-16314, HY-50868, n-(3-((4,5'-bipyrimidin)-2-ylamino)-4-methylphenyl)-4-(((3s)-3-(dimethylamino)-1-pyrrolidinyl)methyl)-3-(trifluoromethyl)benzamide, D10202, D71165, 212D161, Q799775, J-522973, (S)-4-((3-(dimethylamino)pyrrolidin-1-yl)methyl)-N-(4-methyl-3-(4-(pyrimidin-5-yl)pyrimidin-2-ylamino)phenyl)-3-(trifluoromethyl)benzamide, 4-((3-(dimethylamino)pyrrolidin-1-yl)methyl)-N-(4-methyl-3-(4-(pyrimidin-5-yl)pyrimidin-2-ylamino)phenyl)-3-(trifluoromethyl)benzamide, Benzamide, N-(3-((4,5'-bipyrimidin)-2-ylamino)-4-methylphenyl)-4-(((3S)-3-(dimethylamino)-1-pyrrolidinyl)methyl)-3-(trifluoromethyl)-, N-[3-(4,5''-BIPYRIMIDIN-2-YLAMINO)-4-METHYLPHENYL]-4-{[(3S)-3-(DIMETHYLAMINO)PYRROLIDIN-1-YL]METHYL}-3-(TRIFLUOROMETHYL)BENZAMIDE, N-[3-(4,5'-BIPYRIMIDIN-2-YLAMINO)-4-METHYLPHENYL]-4-{[(3S)-3-(DIMETHYLAMINO)PYRROLIDIN-1-YL]METHYL}-3-(TRIFLUOROMETHYL), N-{3-[([4,5'-Bipyrimidin]-2-yl)amino]-4-methylphenyl}-4-{[3-(dimethylamino)pyrrolidin-1-yl]methyl}-3-(trifluoromethyl)benzene-1-carboximidic acid
Pubchem:PUBCHEM:11387605
Id:d2df1b67-71d6-5c65-9815-535b2a44ea0f
Description:nan